Effect of platelet rich plasma versus triamcinolone versus placebo-normal saline in chronic plantar fasciitis: regenerative medicine in orthopaedics

Authors

  • Darshan Gaddenahalli Thimmegowda Department of Orthopaedics, ESIMC and PGIMSR, Rajajinagar, Bangalore, Karnataka, India
  • Lakshmisha Narasimhe Gowda Department of Orthopaedics, Star Hospital, Banjara Hills, Hyderabad, Telangana, India
  • Siddanagouda Patil Department of Orthopaedics, ESIMC and PGIMSR, Rajajinagar, Bangalore, Karnataka, India
  • Siddharath Sharanappa Parmeshwar Department of Orthopaedics, ESIMC and PGIMSR, Rajajinagar, Bangalore, Karnataka, India https://orcid.org/0000-0002-2163-3419
  • Srinath Byrareddy Department of Health and Family Welfare, Karnataka, India

DOI:

https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20242392

Keywords:

Heel pain, Plantar fasciitis, Platelet rich plasma, Triamcinolone

Abstract

Background: Heel pain is a common presenting condition in orthopaedic outpatient units. There are many causes of this condition, but one of the most common is plantar fasciitis. This study was conducted to find out the efficacy of a single injection of platelet-rich plasma versus steroids versus normal saline as a placebo in treating patients suffering from plantar fasciitis.

Methods: Randomized single-blinded placebo-controlled trial with 3 months and 6 months follow-up using visual analogue scale and FAOS (Foot and Ankle Outcome Score) was carried out at a tertiary care hospital for a total of 120 patients (40 patients in each group). First group injected with platelet rich plasma, second group with triamcinolone and third group with normal saline.

Results: Pain relief achieved in the platelet-rich plasma group and triamcinolone group was found to be statistically significant as compared to normal saline at both 3 months and 6 months follow-up. Steroid injection was associated with complications like depigmentation at the injection site and sub dermal atrophy. No complications were found with PRP or normal saline.

Conclusions: This study concludes that the efficacy of a single injection of platelet-rich plasma to relieve the pain of Plantar fasciitis is better than triamcinolone or placebo over a short-term follow-up period. However, more studies are required to evaluate the efficacy of PRP over the long term with multicentric study and comparison with the currently available treatment options.

References

Patel A, DiGiovanni B. Association between plantar fasciitis and isolated contracture of the gastrocnemius. Foot Ankle Int. 2011;32(1):5-8.

Terry CS, Beaty JH, Campbell’s Operative Orthopaedics. 4-Volume Set (Expert Consult Premium Edition - Enhanced Online Features and Print). 2012;4:3954.

Monto RR. Platelet-rich plasma efficacy versus corticosteroid injection treatment for chronic severe plantar fasciitis. Foot Ankle Int. 2014;35(4):313-8.

Jain K, Murphy PN, Clough TM. Platelet rich plasma versus corticosteroid injection for plantar fasciitis: A comparative study. Foot (Edinb). 2015;25(4):235-7.

Hall MP, Band PA, Meislin RJ, Jazrawi LM, Cardone DA. Platelet-rich plasma: current concepts and application in sports medicine. J Am Acad Orthop Surg. 2009;17(10):602-8.

Kaux JF, Crielaard JM. Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthop Belg. 2013;79(1):10-5.

Akşahin E, Doğruyol D, Yüksel HY, Hapa O, Doğan O, Çelebi L. The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis. Arch Orthop Trauma Surg. 2020;132:781-5.

Shetty SH, Dhond A, Arora M, Deore S. Platelet-Rich Plasma Has Better Long-Term Results Than Corticosteroids or Placebo for Chronic Plantar Fasciitis: Randomized Control Trial. J Foot Ankle Surg. 2019;58(1):42-6.

Khandaker MN, Islam MM, Emran MA, Ahmed B, Khan SF, Khasru MR, et al. Impacts of Ultrasonogram-Guided, Intra-fascial, Autologous, Activated Platelet-Rich Plasma Injection in Chronic Plantar Fasciitis: A Quasi-experimental Study. Cureus. 2023;15(2):34659.

Riddle DL, Schappert SM. Volume of ambulatory care visits and patterns of care for patients diagnosed with plantar fasciitis: a national study of medical doctors. Foot ankle int. 2004;25:303-10.

Daniel, Riddle. Risk factors for plantar fasciitis: a matched case-control study. JBJS. 2003;85:872-7.

Acosta-Olivo C, Elizondo-Rodriguez J, Lopez-Cavazos R, Vilchez-Cavazos F, Simental-Mendia M, Mendoza-Lemus O. Plantar fasciitis-a comparison of treatment with intralesional steroids versus platelet-rich plasma a randomized, blinded study. J Am Podiatr Med Assoc. 2017;107(6):490-6.

Sathyendra KG, Dnyandeo SR, Singh M, Venkatesh KS, Singh G, Gupta MM. Comparative study of local injections of autologous platelet rich plasma versus corticosteroid in management of chronic plantar fasciitis. J Clin Orthop Trauma. 2023;43:102225.

Singh P, Madanipour S, Bhamra JS, Gill I. A systematic review and meta-analysis of platelet-rich plasma versus corticosteroid injections for plantar fasciopathy. Int Orthop. 2017;41(6):1169-81.

Pankaj Mahindra et.al: Chronic Plantar Fasciitis: Effect of Platelet- Rich Plasma, Corticosteroid, and Placebo. Orthopaedics. 2016;39:285-9.

Viglione V, Boffa A, Previtali D, Vannini F, Faldini C, Filardo G. The 'placebo effect' in the conservative treatment of plantar fasciitis: a systematic review and meta-analyses. EFORT Open Rev. 2023;8(10):719-30.

Downloads

Published

2024-08-28

Issue

Section

Original Research Articles